Zentalis Pharmaceuticals

ZNTLNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$162.830 M

$1.72 -2.27%

Close of 6 Nov 2026

As of 6 Nov 2026, Zentalis Pharmaceuticals (ZNTL) has a market capitalization of $162.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$137.1M

Loss-making

Shares outstanding

71,671,914

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#256BridgeBio Oncology TherapeuticsBBOT$175.2M
#257Whitehawk TherapeuticsWHWK$173.9M
#258Zentalis PharmaceuticalsZNTL$162.8M
#259Oramed PharmaceuticalsORMP$162.6M
#260PepGenPEPG$160.3M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Zentalis Pharmaceuticals, worth $15.2M. Grants and option exercises are excluded.

WALTERS GROUP, Susan Berkley Walters, William Thurman Walters$15.2M
4,335,000 shares at $3.50 on 14 Aug 2026 · filed 19 Aug 2026

What if Zentalis Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$298,270.85

Per share 173,413× higher

Bitcoin $1.53T

$16,138.92

Per share 9,383× higher

Apple $5.02T

$52,982.56

Per share 30,804× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Zentalis Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.